Sarepta Therapeutics
NASDAQ: SRPT
$108.19
-$2.68 (-2.4%)
Closing price September 23, 2022
Barclays recently issued a few calls across multiple industries implying serious upside for each stock, but one in particular with over 30% upside.
1 month ago
Tuesday's top analyst upgrades and downgrades included Analog Devices, Baxter, BorgWarner, Caesars Entertainment, CarMax, Chevron, Hertz Global, Li Auto, Starbucks, Tesla and Twitter.
5 months ago
Last Updated: 5 months ago
Here are Tuesday's leaders and laggards in the premarket session. Energy stocks were the day's big winners early on.
7 months ago
Tuesday’s top analyst upgrades and downgrades included Bilibili, Carvana, Crocs, GameStop, Goldman Sachs, Nike, Sarepta Therapeutics, Vir Biotechnology and Weber.
8 months ago
Last Updated: 8 months ago
Friday afternoon's analyst upgrades and downgrades included BigCommerce, Citrix, GlaxoSmithKline, Nikola, Regeneron, Shake Shack and more.
10 months ago
Wednesday’s top analyst upgrades and downgrades included Alcoa, Caesars Entertainment, Chevron, DraftKings, Lucid, Sarepta Therapeutics, SoFi Technologies and Wynn Resorts.
1 year ago
Last Updated: 1 year ago
Thursday’s top analyst upgrades and downgrades included Avis Budget, Chewy, Danaher, Eli Lilly, Etsy, Fastly, Halliburton, Robinhood, Roku, Walmart and Western Digital.
1 year ago
Last Updated: 1 year ago
Tuesday’s top analyst upgrades and downgrades included Campbell Soup, Exact Sciences, Exelixis, Pool, Spirit Airlines and ZTO Express.
1 year ago
Last Updated: 1 year ago
Monday's top analyst upgrades and downgrades included Best Buy, Discover Financial, Dollar General, Etsy, HCA Healthcare, KeyCorp, Simon Property, ViacomCBS and Weyerhaeuser.
1 year ago
Last Updated: 1 year ago
Friday's top analyst upgrades and downgrades included Aflac, CME, Chevron, CVS Health, D.R. Horton, Goodyear Tire and Rubber, Lam Research, Micron Technology and U.S. Steel.
1 year ago
Last Updated: 1 year ago
Tuesday's top analyst upgrades and downgrades included Crocs, Gap, GW Pharmaceuticals, Lowe's Companies, Merck, Nio, Palo Alto Networks, Phillips 66, Starbucks and Vital Farms.
2 years ago
Last Updated: 2 years ago
Selecta Biosciences and Sarepta Therapeutics have announced that they had entered into a research license and option agreement.
2 years ago
Here are the biotech companies with exposure to experimental vaccines whose shares saw the biggest boost from this past week's coronavirus news.
2 years ago
Last Updated: 2 years ago
China is facing an outbreak of the coronavirus, which may have spread to a few other countries in Asia. As a result, experimental vaccine stocks are skyrocketing.
2 years ago
Last Updated: 2 years ago
Sarepta shares jumped last week on news that the company reached a licensing deal with Roche. While investors saw about a five-point bump from this news, one analyst sees much more upside for this...
2 years ago
Last Updated: 2 years ago